Literature DB >> 30254053

Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1.

Sam A Jamieson1, Zheng Ruan2, Abigail E Burgess1, Jack R Curry1, Hamish D McMillan1, Jodi L Brewster1, Anita K Dunbier1, Alison D Axtman3,4, Natarajan Kannan2,5, Peter D Mace6.   

Abstract

The Tribbles family of pseudokinases recruits substrates to the ubiquitin ligase COP1 to facilitate ubiquitylation. CCAAT/enhancer-binding protein (C/EBP) family transcription factors are crucial Tribbles substrates in adipocyte and myeloid cell development. We found that the TRIB1 pseudokinase was able to recruit various C/EBP family members and that the binding of C/EBPβ was attenuated by phosphorylation. To explain the mechanism of C/EBP recruitment, we solved the crystal structure of TRIB1 in complex with C/EBPα, which revealed that TRIB1 underwent a substantial conformational change relative to its substrate-free structure and bound C/EBPα in a pseudosubstrate-like manner. Crystallographic analysis and molecular dynamics and subsequent biochemical assays showed that C/EBP binding triggered allosteric changes that link substrate recruitment to COP1 binding. These findings offer a view of pseudokinase regulation with striking parallels to bona fide kinase regulation-by means of the activation loop and αC helix-and raise the possibility of small molecules targeting either the activation "loop-in" or "loop-out" conformations of Tribbles pseudokinases.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30254053      PMCID: PMC6553639          DOI: 10.1126/scisignal.aau0597

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  58 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.

Authors:  Masaichi Hasegawa; Naohiko Nishigaki; Yoshiaki Washio; Kazuya Kano; Philip A Harris; Hideyuki Sato; Ichiro Mori; Rob I West; Megumi Shibahara; Hiroko Toyoda; Liping Wang; Robert T Nolte; James M Veal; Mui Cheung
Journal:  J Med Chem       Date:  2007-08-04       Impact factor: 7.446

3.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

4.  High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.

Authors:  Julia Izrailit; Hal K Berman; Alessandro Datti; Jeffrey L Wrana; Michael Reedijk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

5.  Comparing Conformational Ensembles Using the Kullback-Leibler Divergence Expansion.

Authors:  Christopher L McClendon; Lan Hua; Abriela Barreiro; Matthew P Jacobson
Journal:  J Chem Theory Comput       Date:  2012-04-13       Impact factor: 6.006

6.  C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.

Authors:  Rekha Pal; Martin Janz; Deborah L Galson; Margarete Gries; Shirong Li; Korinna Jöhrens; Ioannis Anagnostopoulos; Bernd Dörken; Markus Y Mapara; Lisa Borghesi; Lela Kardava; G David Roodman; Christine Milcarek; Suzanne Lentzsch
Journal:  Blood       Date:  2009-08-28       Impact factor: 22.113

Review 7.  Structural Basis for the Non-catalytic Functions of Protein Kinases.

Authors:  Jennifer E Kung; Natalia Jura
Journal:  Structure       Date:  2016-01-05       Impact factor: 5.006

8.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

9.  A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.

Authors:  James M Murphy; Qingwei Zhang; Samuel N Young; Michael L Reese; Fiona P Bailey; Patrick A Eyers; Daniela Ungureanu; Henrik Hammaren; Olli Silvennoinen; Leila N Varghese; Kelan Chen; Anne Tripaydonis; Natalia Jura; Koichi Fukuda; Jun Qin; Zachary Nimchuk; Mary Beth Mudgett; Sabine Elowe; Christine L Gee; Ling Liu; Roger J Daly; Gerard Manning; Jeffrey J Babon; Isabelle S Lucet
Journal:  Biochem J       Date:  2014-01-15       Impact factor: 3.857

10.  TRIB2 regulates normal and stress-induced thymocyte proliferation.

Authors:  Kai Ling Liang; Caitriona O'Connor; J Pedro Veiga; Tommie V McCarthy; Karen Keeshan
Journal:  Cell Discov       Date:  2016-03-15       Impact factor: 10.849

View more
  18 in total

1.  The pseudokinase TRIB1 toggles an intramolecular switch to regulate COP1 nuclear export.

Authors:  Jennifer E Kung; Natalia Jura
Journal:  EMBO J       Date:  2019-01-28       Impact factor: 11.598

2.  PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.

Authors:  Mitchell L Lopez; Megan Lo; Jennifer E Kung; Małgorzata Dudkiewicz; Gwendolyn M Jang; John Von Dollen; Jeffrey R Johnson; Nevan J Krogan; Krzysztof Pawłowski; Natalia Jura
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

Review 3.  Trouble With Tribbles-1.

Authors:  Kavita S Jadhav; Robert C Bauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

4.  Tracing the origin and evolution of pseudokinases across the tree of life.

Authors:  Annie Kwon; Steven Scott; Rahil Taujale; Wayland Yeung; Krys J Kochut; Patrick A Eyers; Natarajan Kannan
Journal:  Sci Signal       Date:  2019-04-23       Impact factor: 8.192

Review 5.  Looking lively: emerging principles of pseudokinase signaling.

Authors:  Joshua B Sheetz; Mark A Lemmon
Journal:  Trends Biochem Sci       Date:  2022-05-16       Impact factor: 14.264

6.  Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.

Authors:  Seiko Yoshino; Takashi Yokoyama; Yoshitaka Sunami; Tomoko Takahara; Aya Nakamura; Yukari Yamazaki; Shuichi Tsutsumi; Hiroyuki Aburatani; Takuro Nakamura
Journal:  Blood       Date:  2021-01-07       Impact factor: 22.113

7.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.

Authors:  Daniel M Foulkes; Dominic P Byrne; Wayland Yeung; Safal Shrestha; Fiona P Bailey; Samantha Ferries; Claire E Eyers; Karen Keeshan; Carrow Wells; David H Drewry; William J Zuercher; Natarajan Kannan; Patrick A Eyers
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

8.  Role of Position K+4 in the Phosphorylation and Dephosphorylation Reaction Kinetics of the CheY Response Regulator.

Authors:  Clay A Foster; Ruth E Silversmith; Robert M Immormino; Luke R Vass; Emily N Kennedy; Yael Pazy; Edward J Collins; Robert B Bourret
Journal:  Biochemistry       Date:  2021-06-24       Impact factor: 3.321

9.  In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.

Authors:  Xiaoqing Wang; Collin Tokheim; Shengqing Stan Gu; Binbin Wang; Qin Tang; Yihao Li; Nicole Traugh; Zexian Zeng; Yi Zhang; Ziyi Li; Boning Zhang; Jingxin Fu; Tengfei Xiao; Wei Li; Clifford A Meyer; Jun Chu; Peng Jiang; Paloma Cejas; Klothilda Lim; Henry Long; Myles Brown; X Shirley Liu
Journal:  Cell       Date:  2021-09-27       Impact factor: 66.850

Review 10.  Cataloguing the dead: breathing new life into pseudokinase research.

Authors:  Safal Shrestha; Dominic P Byrne; John A Harris; Natarajan Kannan; Patrick A Eyers
Journal:  FEBS J       Date:  2020-03-10       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.